Skip to main content
. 2023 Oct 15;12(20):2456. doi: 10.3390/cells12202456

Figure 1.

Figure 1

Overview of relevant biomarkers in GBS and CIDP, emphasizing pathogenetically significant locations. (A) Presentation mainly (but not limited to) serum biomarkers, with a focus on infection-triggered markers. (B) Representation primarily (but not exclusively) of biomarkers found in CSF. Of particular pathogenetic significance are structures of the myelin sheath. (C) Known microRNAs as potential biomarkers in GBS/CIDP. Created with BioRender.com.